Evolving consensus for immunomodulatory therapy in non-infectious uveitis during the COVID-19 pandemic.

CONCLUSION: Consensus guidelines were proposed based on global expert opinion and practical experience to bridge the gap between clinical needs and the absence of medical evidence, to guide the treatment of patients with NIU during the COVID-19 pandemic.
PMID: 32586933 [PubMed - as supplied by publisher]

Source: The British Journal of Ophthalmology - June 24, 2020 Category: Opthalmology Authors: Agrawal R, Testi I, Lee CS, Tsui E, Blazes M, Thorne JE, Okada AA, Smith JR, McCluskey PJ, Kempen JH, Christoph T, Agarwal M, Bodaghi B, Nguyen QD, Gupta V, De Smet MD, Zierhut M, Pavesio C, COVID-19 IMT Study Group Tags: Br J Ophthalmol Source Type: research